Year |
Citation |
Score |
2020 |
Slenders JPL, Van den Berg-Vos RM, van Heugten CM, Visser-Meily JMA, Evers SMAA, de Haan RJ, de Man-van Ginkel JM, Kwa VIH. Screening and patient-tailored care for emotional and cognitive problems compared to care as usual in patients discharged home after ischemic stroke (ECO-stroke): a protocol for a multicenter, patient-blinded, cluster randomized controlled trial. Bmc Health Services Research. 20: 1049. PMID 33203405 DOI: 10.1186/s12913-020-05902-2 |
0.339 |
|
2014 |
Zinkstok SM, Beenen LF, Majoie CB, Marquering HA, de Haan RJ, Roos YB. Early deterioration after thrombolysis plus aspirin in acute stroke: a post hoc analysis of the Antiplatelet Therapy in Combination with Recombinant t-PA Thrombolysis in Ischemic Stroke trial. Stroke; a Journal of Cerebral Circulation. 45: 3080-2. PMID 25139873 DOI: 10.1161/STROKEAHA.114.006268 |
0.302 |
|
2011 |
Nederkoorn PJ, Westendorp WF, Hooijenga IJ, de Haan RJ, Dippel DW, Vermeij FH, Dijkgraaf MG, Prins JM, Spanjaard L, van de Beek D. Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. International Journal of Stroke : Official Journal of the International Stroke Society. 6: 159-63. PMID 21371281 DOI: 10.1111/j.1747-4949.2010.00555.x |
0.336 |
|
2010 |
Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB. A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial. Trials. 11: 51. PMID 20459856 DOI: 10.1186/1745-6215-11-51 |
0.314 |
|
2010 |
Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial. Cerebrovascular Diseases (Basel, Switzerland). 29: 79-81. PMID 19907167 DOI: 10.1159/000256651 |
0.319 |
|
2008 |
Weisscher N, Vermeulen M, Roos YB, de Haan RJ. What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? Journal of Neurology. 255: 867-74. PMID 18338195 DOI: 10.1007/s00415-008-0796-8 |
0.34 |
|
2008 |
Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke; a Journal of Cerebral Circulation. 39: 497-502. PMID 18174491 DOI: 10.1161/STROKEAHA.107.488791 |
0.341 |
|
2006 |
Meijer R, Van Limbeek J, De Haan R. Development of the Stroke-unit Discharge Guideline: Choice of assessment instruments for prediction in the subacute phase post-stroke International Journal of Rehabilitation Research. 29: 1-8. PMID 16432383 DOI: 10.1097/01.mrr.0000175269.59788.41 |
0.337 |
|
2005 |
Boter H, de Haan RJ, Rinkel GJ. Regional differences in the use of out-patient services by stroke patients after hospitalisation. European Neurology. 53: 10-4. PMID 15627774 DOI: 10.1159/000082955 |
0.343 |
|
2003 |
Boter H, De Haan RJ, Rinkel GJ. Clinimetric evaluation of a Satisfaction-with-Stroke-Care questionnaire. Journal of Neurology. 250: 534-41. PMID 12736731 DOI: 10.1007/S00415-003-1031-2 |
0.336 |
|
2002 |
de Haan RJ. Measuring quality of life after stroke using the SF-36. Stroke; a Journal of Cerebral Circulation. 33: 1176-7. PMID 11988583 DOI: 10.1161/01.STR.0000015223.98452.97 |
0.322 |
|
2001 |
van Straten A, Reitsma JB, Limburg M, van den Bos GA, de Haan RJ. Impact of stroke type on survival and functional health. Cerebrovascular Diseases (Basel, Switzerland). 12: 27-33. PMID 11435676 DOI: 10.1159/000047677 |
0.314 |
|
2001 |
Horn J, de Haan RJ, Vermeulen M, Limburg M. Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial. Stroke; a Journal of Cerebral Circulation. 32: 461-5. PMID 11157183 |
0.319 |
|
2000 |
van Straten A, de Haan RJ, Limburg M, van den Bos GA. Clinical meaning of the Stroke-Adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136. Stroke; a Journal of Cerebral Circulation. 31: 2610-5. PMID 11062283 |
0.397 |
|
1998 |
Scholte op Reimer WJ, de Haan RJ, Pijnenborg JM, Limburg M, van den Bos GA. Assessment of burden in partners of stroke patients with the sense of competence questionnaire. Stroke; a Journal of Cerebral Circulation. 29: 373-9. PMID 9472877 |
0.392 |
|
1997 |
van Straten A, de Haan RJ, Limburg M, Schuling J, Bossuyt PM, van den Bos GA. A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30). Stroke; a Journal of Cerebral Circulation. 28: 2155-61. PMID 9368557 |
0.407 |
|
1997 |
Sneeuw KC, Aaronson NK, de Haan RJ, Limburg M. Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke; a Journal of Cerebral Circulation. 28: 1541-9. PMID 9259746 |
0.47 |
|
1996 |
Kwa VI, Limburg M, de Haan RJ. The role of cognitive impairment in the quality of life after ischaemic stroke. Journal of Neurology. 243: 599-604. PMID 8865027 |
0.334 |
|
1995 |
de Haan RJ, Limburg M, Van der Meulen JH, Jacobs HM, Aaronson NK. Quality of life after stroke. Impact of stroke type and lesion location. Stroke; a Journal of Cerebral Circulation. 26: 402-8. PMID 7886714 |
0.445 |
|
1995 |
Lindeboom R, De Haan R, Aramideh M, Speelman JD. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 444-9. PMID 7565824 DOI: 10.1002/MDS.870100407 |
0.312 |
|
1995 |
de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke; a Journal of Cerebral Circulation. 26: 2027-30. PMID 7482643 DOI: 10.1161/01.STR.26.11.2027 |
0.459 |
|
1993 |
de Haan R, Aaronson N, Limburg M, Hewer RL, van Crevel H. Measuring quality of life in stroke. Stroke; a Journal of Cerebral Circulation. 24: 320-7. PMID 8421836 DOI: 10.1161/01.STR.24.2.320 |
0.437 |
|
1993 |
De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke; a Journal of Cerebral Circulation. 24: 1178-81. PMID 8342193 |
0.37 |
|
Show low-probability matches. |